Sildalis (sildenafil + tadalafil)
Sildalis combines two ED medicines, sildenafil and tadalafil, in one tablet. The maker is not established. See the concerns.
- Active ingredients
- Sildenafil + Tadalafil
- Form
- Tablet
- Company
- Not established
Sildalis is described in secondary listings as sildenafil 100 mg plus tadalafil 20 mg. This review has not confirmed a consistent manufacturer or an exact company catalogue record for that spelling. Its claimed amounts and identity remain qualified.
A similar name is not confirmation
RSM Enterprises lists a product called Sildalist. That near-match does not establish that Sildalis is the same supplied medicine. The spelling, company, composition and pack need to agree before a supplier record is attached to this entry.
Two ED ingredients are different from ED plus PE
Both claimed ingredients are PDE5 inhibitors, addressing erection response. This is not a sildenafil–dapoxetine combination with a separate ejaculation-control ingredient. The amounts correspond to the maximum single as-needed ED amounts in the respective reference labels, but reference amounts cannot validate a tablet combining them.
The checked sildenafil and tadalafil labels advise against unassessed combinations with other ED treatments. We have not identified a product-specific trial establishing this Sildalis formulation’s benefit or safety. That does not mean every possible combination has never been researched; it means those results have not established this product.
Read the combination guide and sourcing checks before treating a two-ingredient seller name as a proven upgrade.
Product record
- Company
- Not established
- Strengths listed
- Sildenafil 100 mg + tadalafil 20 mg (secondary listings)
- Treatment area
- Erectile dysfunction (ED)
- Identity
- Not confirmed in Indian pharmacy databases or a manufacturer catalogue
- Record reviewed
- 4 October 2026; source retrieval dates are retained with the evidence
Listed strengths identify a product; they are not dosing advice. A listing in one country does not show that a product is authorized where you live.
About sildenafil
Sildenafil supports the erection response to stimulation. Food can delay absorption of ordinary film-coated tablets; blood half-life is not a guaranteed response window. Timed follow-up can help explain an apparent nonresponse.
About tadalafil
Tadalafil can offer a response window up to 36 hours with stimulation, not a continuous erection. Daily and as-needed regimens differ; food does not change absorption in the reference label. Longer exposure also matters for interactions.
About unverified names
This profile has historical, supplier or incomplete identity evidence. Some names have a company catalogue association; others have secondary listings with unresolved details. Read the exact source and remaining gap rather than assuming every unfamiliar name has no company evidence.
About fixed combinations
A fixed combination puts two medicines in one tablet at set doses. Each ingredient brings its own side effects and interactions, and approval of each ingredient on its own does not mean the combination is approved or suitable.
Do not add another ED or PE medicine to a combination product.
Using a PDE5 inhibitor safely
Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.
Common side effects include headache, flushing, indigestion and a blocked nose.
Sources
2 sources
Checked .
- VIAGRA (sildenafil) US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.
- CIALIS (tadalafil) US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.